Message for general practitioners on clinical eligibility
Publication date: 26 January 2021
This is a joint message from the Royal College of General Practitioners and RCPCH on clinical eligibility of children and young people for COVID-19 vaccines in phase 1 of the vaccination programme.
There is understandably considerable interest among paediatricians, general practitioners, and their patients, in the rollout of the COVID-19 vaccination programme. This is particularly so in those patients who have been shielding for much of the last year due to their extreme clinical vulnerabilities.
We are now in the first phase of the programme during which young people (aged 16 years and over) with specific clinical vulnerabilities will be offered vaccination1.
The only other group identified by the Joint Committee on Vaccination and Immunisation (JCVI) and the Green Book2 that should be considered for the vaccine during phase 1 are older children (aged 12 years and over) with severe neuro-disabilities and recurrent respiratory tract infections who require residential care. Such vaccinations would be considered unlicensed use3, and paediatricians and general practitioners should discuss the benefits and risks and limited safety data with children, young people and their parents/guardians. Any vaccination would need to be authorised by a prescriber (usually a doctor).
It is important to stress that at this time the JCVI consider that there are no data to support use of the vaccine in younger age groups or other clinical groups, and we support this view. While this is the case, vaccinations should not be offered to children and young people who fall outside the categories advised by the JCVI and the Green Book. With studies to generate the data for children and young people due to start, evidence will be generated as quickly as possible to enable safe rollout to children and young people.
7 January Lockdown 'advice' letters for clinically extremely vulnerable people in England
We are aware that clinically extremely vulnerable children and young people in England have received letters recently suggesting they would be invited for vaccinations in the next month despite not meeting the criteria outlined by the JCVI. We know these letters have caused confusion and upset for families and paediatricians. These letters should not be solely relied upon to identify those eligible for vaccination at this time, rather we strongly advise all general practitioners, paediatricians and others involved in vaccination to adhere to the advice provided by the JCVI and the Green Book.
- Those who are clinically extremely vulnerable will be eligible for vaccination in priority group 4 (after those aged 75 and over). Those with other clinical vulnerabilities specified by the JCVI will be eligible for the vaccine in priority group 6 (after those aged 65 and over). For further details see the UK government website.
- The Green Book, chapter 14a, version 5 (published 21 January 2021)
- The Pfizer BioNTech vaccine is authorised for 16 years and over, the AstraZeneca vaccine for 18 years and over.
(For media only)
RCGP Press office – 020 3188 7633/7494/7574
Out of hours: 0203 188 7659
Notes to editor
The Royal College of General Practitioners is a network of more than 53,000 family doctors working to improve care for patients. We work to encourage and maintain the highest standards of general medical practice and act as the voice of GPs on education, training, research and clinical standards.